Avery Dennison Corp·4

Mar 3, 4:36 PM ET

STANDER DEON 4

4 · Avery Dennison Corp · Filed Mar 3, 2026

Research Summary

AI-generated summary of this filing

Updated

Avery Dennison (AVY) CEO Deon Stander Exercises Options, Receives Awards

What Happened
Deon Stander, President & CEO and a director of Avery Dennison (AVY), exercised stock derivatives on March 1, 2026, acquiring 14,193 shares by paying an exercise price of $194.78 per share (total cash paid ≈ $2,764,513). To cover the related exercise price/tax liability, 5,986 shares were withheld (disposed) at the same $194.78 rate (value ≈ $1,165,953). In addition, several performance/market stock unit tranches vested/converted into a total of 40,655 share equivalents (grants reported at $0). The exercises represent a cash exercise with shares withheld for tax—part buy, part withholding—while the vested awards were converted into common shares.

Key Details

  • Transaction date: March 1, 2026; Form 4 filed March 3, 2026 (appears timely).
  • Option exercises (paid): 14,193 shares at $194.78 — gross cash paid ≈ $2,764,513.
  • Shares withheld for taxes (F code): 5,986 shares at $194.78 — value ≈ $1,165,953.
  • Award grants/vesting (A code): 16,622 and 24,033 share units = 40,655 MSUs/PUs acquired (reported at $0).
  • Net shares retained from the cash exercises: 14,193 − 5,986 = 8,207 shares (plus 40,655 vested award shares converted).
  • Shares owned after transaction: not disclosed in this filing.
  • Notable footnotes: RSUs vest 25% annually (F1); PUs vest based on performance with final determination in 2029 (F2); MSU/PUs vested at partial percentages of target per F3–F7 (shows vesting at 92%–96% for MSU tranches and 56% for certain PUs).
  • Transaction codes explained: M = option exercise/conversion, F = payment of exercise price/tax withholding, A = grant/award acquisition.

Context

  • This filing shows a cash option exercise (insider paid exercise price) combined with tax withholding of shares rather than a market sale—common for covering taxes. The vesting/conversion of MSUs and PUs reflects performance-based awards paying out at partial percentages of target per the footnotes.
  • Exercises and vesting are routine for executives with equity compensation and do not by themselves indicate intent to buy or sell stock in the open market. Purchases (cash exercises where shares are retained) are often watched as a more direct bullish signal.

Insider Transaction Report

Form 4
Period: 2026-03-01
STANDER DEON
DirectorPresident & CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2026-03-01$194.78/sh+1,824$355,27966,968 total
  • Tax Payment

    Common Stock

    2026-03-01$194.78/sh544$105,96066,424 total
  • Exercise/Conversion

    Common Stock

    2026-03-01$194.78/sh+1,382$269,18667,806 total
  • Tax Payment

    Common Stock

    2026-03-01$194.78/sh412$80,24967,394 total
  • Exercise/Conversion

    Common Stock

    2026-03-01$194.78/sh+3,033$590,76870,427 total
  • Tax Payment

    Common Stock

    2026-03-01$194.78/sh1,146$223,21869,281 total
  • Exercise/Conversion

    Common Stock

    2026-03-01$194.78/sh+4,854$945,46274,135 total
  • Tax Payment

    Common Stock

    2026-03-01$194.78/sh2,370$461,62971,765 total
  • Exercise/Conversion

    Common Stock

    2026-03-01$194.78/sh+3,100$603,81874,865 total
  • Tax Payment

    Common Stock

    2026-03-01$194.78/sh1,514$294,89773,351 total
  • Award

    2026 RSU Award

    [F1]
    2026-03-01+16,62216,622 total
    Exercise: $0.00From: 2027-03-01Exp: 2030-03-01Common Stock (16,622 underlying)
  • Award

    2026 PU Award

    [F2]
    2026-03-01+24,03324,033 total
    Exercise: $0.00From: 2029-03-01Exp: 2029-03-01Common Stock (24,033 underlying)
  • Exercise/Conversion

    2022 MSU Award

    [F3]
    2026-03-011,8240 total
    Exercise: $0.00From: 2023-03-01Exp: 2026-03-01Common Stock (1,824 underlying)
  • Exercise/Conversion

    2023 MSU Award

    [F4]
    2026-03-011,3821,364 total
    Exercise: $0.00From: 2024-03-01Exp: 2027-03-01Common Stock (1,382 underlying)
  • Exercise/Conversion

    2024 MSU Award

    [F5]
    2026-03-013,0336,353 total
    Exercise: $0.00From: 2025-03-01Exp: 2028-03-01Common Stock (3,033 underlying)
  • Exercise/Conversion

    2025 MSU Award

    [F6]
    2026-03-014,85415,170 total
    Exercise: $0.00From: 2026-03-01Exp: 2029-03-01Common Stock (4,854 underlying)
  • Exercise/Conversion

    2023 PU Award

    [F7]
    2026-03-013,1000 total
    Exercise: $0.00From: 2026-03-01Exp: 2026-03-01Common Stock (3,100 underlying)
Footnotes (7)
  • [F1]Restricted stock units (RSUs) vest 25% on each of the first, second, third and fourth anniversaries of the grant date. Each RSU represents a contingent right to receive one share of common stock.
  • [F2]Performance units (PUs) vest, at the end of fiscal year 2028, provided certain performance objectives are met as determined by the Compensation Committee in February 2029. Each PU represents a contingent right to receive one share of common stock.
  • [F3]Shares reflect the vesting of the fourth tranche of MSUs granted in February 2022 at 92% of target based on our absolute total stockholder return in excess of 10% during the 2022-2025 performance period, plus dividend equivalents accrued during the period.
  • [F4]Shares reflect the vesting of the third tranche of MSUs granted in March 2023 at 96% of target based on our absolute total stockholder return during the 2023-2025 performance period, plus dividend equivalents accrued during the period.
  • [F5]Shares reflect the vesting of the second tranche of MSUs granted in March 2024 at 92% of target based on our absolute total stockholder return during the 2024-2025 performance period, plus dividend equivalents accrued during the period.
  • [F6]Shares reflect the vesting of the first tranche of MSUs granted in March 2025 at 94% of target based on our absolute total stockholder return during the 2025 performance period, plus dividend equivalents accrued during the period.
  • [F7]Shares reflect the vesting of PUs granted in March 2023 at 56% of target, based 50% on our cumulative economic value added of 0% of target and 50% on our relative total stockholder return of 112% of target.
Signature
/s/ Vikas Arora, attorney-in-fact for Deon Stander|2026-03-03

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT